BENUSSI, Alberto
 Distribuzione geografica
Continente #
NA - Nord America 6.459
AS - Asia 3.871
EU - Europa 2.773
SA - Sud America 810
AF - Africa 93
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 6
Totale 14.023
Nazione #
US - Stati Uniti d'America 6.306
SG - Singapore 1.461
CN - Cina 1.104
BR - Brasile 698
IT - Italia 679
HK - Hong Kong 527
DE - Germania 506
UA - Ucraina 365
GB - Regno Unito 271
VN - Vietnam 259
FI - Finlandia 239
RU - Federazione Russa 191
TR - Turchia 151
IE - Irlanda 132
FR - Francia 101
IN - India 80
CA - Canada 72
BD - Bangladesh 66
MX - Messico 56
AR - Argentina 47
ZA - Sudafrica 47
NL - Olanda 44
CZ - Repubblica Ceca 43
PL - Polonia 42
BE - Belgio 38
IQ - Iraq 32
SE - Svezia 31
JP - Giappone 30
AT - Austria 25
ES - Italia 25
PK - Pakistan 18
SA - Arabia Saudita 18
UZ - Uzbekistan 18
ID - Indonesia 14
MA - Marocco 13
EC - Ecuador 12
PY - Paraguay 12
CO - Colombia 10
IL - Israele 10
TW - Taiwan 10
AU - Australia 9
UY - Uruguay 9
VE - Venezuela 9
AE - Emirati Arabi Uniti 8
AZ - Azerbaigian 8
JO - Giordania 8
LT - Lituania 8
NP - Nepal 7
CL - Cile 6
DK - Danimarca 6
DO - Repubblica Dominicana 6
IR - Iran 6
EG - Egitto 5
KG - Kirghizistan 5
LB - Libano 5
PH - Filippine 5
RO - Romania 5
TN - Tunisia 5
BH - Bahrain 4
BY - Bielorussia 4
CR - Costa Rica 4
DZ - Algeria 4
EU - Europa 4
JM - Giamaica 4
KE - Kenya 4
KZ - Kazakistan 4
BG - Bulgaria 3
BO - Bolivia 3
CI - Costa d'Avorio 3
EE - Estonia 3
HN - Honduras 3
OM - Oman 3
PE - Perù 3
SN - Senegal 3
CH - Svizzera 2
GA - Gabon 2
GD - Grenada 2
GE - Georgia 2
GR - Grecia 2
KR - Corea 2
MD - Moldavia 2
MY - Malesia 2
NG - Nigeria 2
NZ - Nuova Zelanda 2
PT - Portogallo 2
TT - Trinidad e Tobago 2
XK - ???statistics.table.value.countryCode.XK??? 2
AL - Albania 1
AM - Armenia 1
AW - Aruba 1
CG - Congo 1
DM - Dominica 1
ET - Etiopia 1
GT - Guatemala 1
KW - Kuwait 1
LU - Lussemburgo 1
MU - Mauritius 1
NI - Nicaragua 1
NO - Norvegia 1
PS - Palestinian Territory 1
Totale 14.018
Città #
Fairfield 699
Singapore 668
Ashburn 566
Hong Kong 523
Woodbridge 384
Chandler 318
Beijing 305
Jacksonville 295
New York 286
Seattle 254
Wilmington 253
Houston 251
Cambridge 249
Ann Arbor 227
Princeton 200
Los Angeles 178
Helsinki 165
Munich 154
Dublin 132
The Dalles 130
Istanbul 124
Milan 103
Dallas 102
Ho Chi Minh City 99
Brescia 96
São Paulo 88
Nanjing 82
Dearborn 75
Redondo Beach 68
Des Moines 67
Shanghai 64
San Francisco 61
Moscow 60
Turku 60
Chicago 53
Buffalo 49
Hanoi 49
London 45
Jinan 40
Boardman 38
Brussels 38
Nanchang 36
San Diego 36
Santa Clara 36
Warsaw 36
Nuremberg 35
Hebei 33
Denver 32
Changsha 31
Johannesburg 30
Olomouc 30
Phoenix 29
Shenyang 29
Rome 25
Brooklyn 24
Montreal 24
Tokyo 23
Atlanta 21
Mexico City 21
Belo Horizonte 20
Charlotte 20
Lancaster 20
Guangzhou 19
Toronto 18
Boston 17
Chennai 17
Mumbai 17
Rio de Janeiro 17
Stockholm 17
Frankfurt am Main 16
Manchester 16
Tianjin 16
Dhaka 15
Hangzhou 15
Norwalk 15
San Mateo 15
Tashkent 15
Kunming 14
Ningbo 14
Poplar 14
Vienna 14
Amsterdam 13
Augusta 13
Jiaxing 13
Brno 12
Orem 12
Romola 12
Taizhou 12
Da Nang 11
Düsseldorf 11
Kocaeli 11
Washington 11
Erbil 10
Baghdad 9
Honolulu 9
Naples 9
Riyadh 9
Taipei 9
Taiyuan 9
Trieste 9
Totale 8.794
Nome #
Discrimination of atypical parkinsonisms with transcranial magnetic stimulation 217
COVID-19 impact on consecutive neurological patients admitted to the emergency department 213
Mild Cognitive Impairment and Progression to Dementia in Progressive Supranuclear Palsy 207
Mendelian forms of disease and age at onset affect survival in frontotemporal dementia 197
Diagnosis of Mild Cognitive Impairment Due to Alzheimer's Disease with Transcranial Magnetic Stimulation 192
Cortico-spinal tDCS in ALS: A randomized, double-blind, sham-controlled trial 190
Clinical characteristics and outcomes of inpatients with neurologic disease and COVID-19 in Brescia, Lombardy, Italy 178
Transcranial magnetic stimulation distinguishes Alzheimer disease from frontotemporal dementia 169
Autoimmunity and frontotemporal dementia 166
The impact of transcranial magnetic stimulation on diagnostic confidence in patients with Alzheimer disease 164
Stimulation over the cerebellum with a regular figure-of-eight coil induces reduced motor cortex inhibition in patients with progressive supranuclear palsy 163
Metodo di generazione di un indice diagnostico per malattia di alzheimer, apparato elettronico di implementazione del metodo e sistema 158
Diagnosing Progressive Supranuclear Palsy: Role of Biological and Neuroimaging Markers 155
Sensitivity and specificity of transcranial magnetic stimulation for differential diagnosis of Alzheimer’s disease and frontotemporal dementia 154
Clinical and biomarker changes in presymptomatic genetic frontotemporal dementia 154
Anti-GluA3 antibodies in frontotemporal dementia: effects on glutamatergic neurotransmission and synaptic failure 154
Enhancing theory of mind in behavioural variant frontotemporal dementia with transcranial direct current stimulation 154
Cerebellar transcranial direct current stimulation in patients with ataxia: A double-blind, randomized, sham-controlled study. 151
Natural history and predictors of survival in progressive supranuclear palsy. 139
Multimodal Brain Analysis of Functional Neurological Disorders: A Functional Stroke Mimic Case Series. 139
Response to comments on natural history and predictors of survival in progressive supranuclear palsy 138
Author response: Cerebello-spinal tDCS in ataxia: A randomized, double-blind, sham-controlled, crossover trial 136
Phenotypic heterogeneity of Niemann-Pick disease type C in monozygotic twins. 135
Neuroanatomical Correlates of Transcranial Magnetic Stimulation in Presymptomatic Granulin Mutation Carriers. 135
Phenotypic Heterogeneity of Monogenic Frontotemporal Dementia. 134
Cerebrospinal fluid tau levels predict prognosis in non-inherited frontotemporal dementia. 134
Biological, Neuroimaging, and Neurophysiological Markers in Frontotemporal Dementia: Three Faces of the Same Coin. 133
The impact of TMS on the differential diagnosis and progression of dementia 132
Modulating risky decision-making in Parkinson's disease by transcranial direct current stimulation. 131
Clinical, genetic, and neuroimaging features of Early Onset Alzheimer Disease: the challenges of diagnosis and treatment. 130
Preliminary Results on Long-Term Potentiation-Like Cortical Plasticity and Cholinergic Dysfunction After Miglustat Treatment in Niemann-Pick Disease Type C. 130
Method of generation of a diagnostic index for Alzheimer disease, electronic apparatus for implementation of the method and system 129
Serum neurofilament light in professional soccer players: goal on safety 126
Embedded platform-based system for early detection of Alzheimer disease through transcranial magnetic stimulation 125
Clinical presentation and outcomes of SARS-CoV-2 related encephalitis: the ENCOVID multicentre study 124
Facial feedback and autonomic responsiveness reflect impaired emotional processing in Parkinson's Disease. 123
Long term clinical and neurophysiological effects of cerebellar transcranial direct current stimulation in patients with neurodegenerative ataxia. 121
TMS for staging and predicting functional decline in frontotemporal dementia 121
Recent neuroimaging, neurophysiological, and neuropathological advances for the understanding of NPC 120
Treatment with docosahexaenoic acid in Spinocerebellar Ataxia 38 118
Progression of behavioural disturbances in frontotemporal dementia: a longitudinal observational study 118
Cerebello-spinal tDCS in ataxia: A randomized, double-blind, sham-controlled, crossover trial 117
Modulation of long-term potentiation-like cortical plasticity in the healthy brain with low frequency-pulsed electromagnetic fields 116
Impaired long-term potentiation-like cortical plasticity in presymptomatic genetic frontotemporal dementia. 115
Age at symptom onset and death and disease duration in genetic frontotemporal dementia: an international retrospective cohort study 115
Clinical and neurophysiological characteristics of heterozygous NPC1 carriers 115
Toward a Glutamate Hypothesis of Frontotemporal Dementia 114
Validation and convergent validity of the Boston cognitive assessment (BOCA) in an Italian population: a comparative study with the Montreal cognitive assessment (MoCA) in Alzheimer's disease spectrum 112
New insights into the genetic etiology of Alzheimer’s disease and related dementias 112
Italian Frontotemporal Dementia Network (FTD Group-SINDEM): sharing clinical and diagnostic procedures in Frontotemporal Dementia in Italy. 112
Csf p-tau181/tau ratio as biomarker for TDP pathology in frontotemporal dementia. 112
Variability and predictors of response to continuous theta burst stimulation: A TMS-EEG study 111
Mild cognitive impairment in Parkinson's disease is improved by transcranial direct current stimulation combined with physical therapy. 110
Cerebello-spinal stimulation in neurodegenerative ataxia: A randomized, double-blind, sham-controlled, crossover trial 110
Classification accuracy of TMS for the diagnosis of mild cognitive impairment 109
Transcranial magnetic stimulation and amyloid markers in mild cognitive impairment: Impact on diagnostic confidence and diagnostic accuracy 107
Cortical Inhibitory Imbalance in Functional Paralysis 105
Progression of Behavioral Disturbances and Neuropsychiatric Symptoms in Patients With Genetic Frontotemporal Dementia 105
CSF p-Tau181/Tau ratio to distinguish FTLD-TDP from FTLD-Tau 104
Classification Accuracy of Transcranial Magnetic Stimulation for the Diagnosis of Neurodegenerative Dementias 104
Transcranial Magnetic Stimulation in Alzheimer's Disease and Cortical Dementias 103
Hierarchical spectral clustering reveals brain size and shape changes in asymptomatic carriers of C9orf72 101
Data-driven staging of genetic frontotemporal dementia using multi-modal MRI 100
MRI data-driven algorithm for the diagnosis of behavioural variant frontotemporal dementia 100
SARS-CoV-2 encephalitis is a cytokine release syndrome: evidences from cerebrospinal fluid analyses 99
Stratifying the Presymptomatic Phase of Genetic Frontotemporal Dementia by Serum NfL and pNfH: A Longitudinal Multicentre Study 98
Expanding the role of education in frontotemporal dementia: a functional dynamic connectivity (the chronnectome) study 96
A panel of CSF proteins separates genetic frontotemporal dementia from presymptomatic mutation carriers: a GENFI study 96
An Automated Toolbox to Predict Single Subject Atrophy in Presymptomatic Granulin Mutation Carriers 96
A data-driven disease progression model of fluid biomarkers in genetic frontotemporal dementia 95
Altered inhibitory interaction among inferior frontal and motor cortex in l-dopa-induced dyskinesias 95
Neurophysiological Correlates of Positive and Negative Symptoms in Frontotemporal Dementia 94
CSF p-Tau181/Tau ratio as biomarker for TDP pathology in Frontotemporal Dementia 93
Alterations of frontal-temporal gray matter volume associate with clinical measures of older adults with COVID-19 91
Cognitive composites for genetic frontotemporal dementia: GENFI-Cog 91
Diagnostic Accuracy of the Five-Word Test for Mild Cognitive Impairment Due to Alzheimer’s Disease 90
Impairment of episodic memory in genetic frontotemporal dementia: A genfi study 88
Exposure to gamma tACS in Alzheimer's disease: A randomized, double-blind, sham-controlled, crossover, pilot study 88
Clinical outcome of neurological patients with COVID-19: the impact of healthcare organization improvement between waves 87
Clinical and radiological features of posterior cortical atrophy (PCA) in a GRN mutation carrier: a case report 85
Transcranial stimulation in frontotemporal dementia: A randomized, double-blind, sham-controlled trial 83
Imaging features and ultraearly hematoma growth in intracerebral hemorrhage associated with COVID-19 83
Sex Differences in the Severity and Progression of Neuropsychiatric Symptoms Across Different Dementia Types 83
Prevalence of cerebrospinal fluid Alzheimer disease-like pattern in atypical dementias 82
Dissemination in time and space in presymptomatic granulin mutation carriers: a GENFI spatial chronnectome study 81
Effects of COVID-19 outbreak on stroke admissions in Brescia, Lombardy, Italy 80
Differential impairment of cerebrospinal fluid synaptic biomarkers in the genetic forms of frontotemporal dementia 79
Recent advances in understanding frontotemporal degeneration 77
Diagnostic and prognostic value of serum NfL and p-Tau181 in frontotemporal lobar degeneration 77
Differences and similarities between familial and sporadic frontotemporal dementia: An Italian single-center cohort study 76
Differential early subcortical involvement in genetic FTD within the GENFI cohort 75
Differences Between Plasma and Cerebrospinal Fluid p-tau181 and p-tau231 in Early Alzheimer's Disease 74
Author Correction: Common variants in Alzheimer's disease and risk stratification by polygenic risk scores 73
Conceptual framework for the definition of preclinical and prodromal frontotemporal dementia 73
The role of transcranial magnetic stimulation in the diagnosis of dementia 72
A novel CSF1R mutation mimicking frontotemporal dementia: A glimpse into a microgliopathy 71
The CBI-R detects early behavioural impairment in genetic frontotemporal dementia 71
Voluntary inhibitory control and impulsivity in Parkinson’s disease patients with and without levodopa-induced dyskinesias 69
Aberrant origin of the occipital artery from the internal carotid artery: utility of the occipital tap maneuver 69
Prodromal frontotemporal dementia: clinical features and predictors of progression 69
Totale 11.615
Categoria #
all - tutte 81.089
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 81.089


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021911 0 0 0 0 0 127 66 149 126 204 176 63
2021/2022861 61 71 27 34 10 52 86 82 55 97 100 186
2022/20231.071 121 65 48 71 76 244 24 89 148 55 65 65
2023/20241.216 78 32 148 72 37 239 32 55 248 35 35 205
2024/20253.193 46 19 25 519 283 253 235 125 422 305 560 401
2025/20263.751 621 790 483 916 624 317 0 0 0 0 0 0
Totale 14.268